Sante Ventures — 2010 Investments
1 investments dated 2010 · listed companies and verified rows first · show all
Endostimendostim.comin𝕏Series B · Jul 2010 · $6M
EndoStim develops a neurostimulation medical device system for treating drug-resistant gastroesophageal reflux disease (GERD) by restoring esophageal function while preserving normal anatomy.
BiotechHealthtechMedical DevicesSt. Louis, US
Eric Goorno(Chief Executive Officer)Greg Wilson(Chief Financial Officer)Stephen Attwood, MD(Surgical Director)Virender Sharma, MD(Chief Medical Officer)Hazim Ansari(Chief Legal Counsel)Bevil J. Hogg(Executive Officer, Director)
Co-investorsRelevance Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.